CN114794241A - 高脂人乳产品 - Google Patents
高脂人乳产品 Download PDFInfo
- Publication number
- CN114794241A CN114794241A CN202210553069.1A CN202210553069A CN114794241A CN 114794241 A CN114794241 A CN 114794241A CN 202210553069 A CN202210553069 A CN 202210553069A CN 114794241 A CN114794241 A CN 114794241A
- Authority
- CN
- China
- Prior art keywords
- human milk
- milk
- human
- milk fat
- fat composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020256 human milk Nutrition 0.000 title claims abstract description 223
- 210000004251 human milk Anatomy 0.000 title claims abstract description 223
- 239000000203 mixture Substances 0.000 claims abstract description 96
- 238000000034 method Methods 0.000 claims abstract description 36
- 235000016709 nutrition Nutrition 0.000 claims description 28
- 208000018773 low birth weight Diseases 0.000 claims description 21
- 231100000533 low birth weight Toxicity 0.000 claims description 21
- 235000020183 skimmed milk Nutrition 0.000 claims description 19
- 230000035764 nutrition Effects 0.000 claims description 18
- 230000012010 growth Effects 0.000 claims description 12
- 239000012466 permeate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000019786 weight gain Nutrition 0.000 claims description 8
- 230000004584 weight gain Effects 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 235000020200 pasteurised milk Nutrition 0.000 claims description 3
- 239000006071 cream Substances 0.000 abstract description 15
- 210000004080 milk Anatomy 0.000 description 44
- 239000008267 milk Substances 0.000 description 44
- 235000013336 milk Nutrition 0.000 description 43
- 235000021243 milk fat Nutrition 0.000 description 40
- 230000035611 feeding Effects 0.000 description 26
- 239000000047 product Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 239000000523 sample Substances 0.000 description 15
- 235000021476 total parenteral nutrition Nutrition 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 10
- 235000013350 formula milk Nutrition 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 238000009928 pasteurization Methods 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 230000002028 premature Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000013074 reference sample Substances 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- 241000711549 Hepacivirus C Species 0.000 description 5
- 239000000356 contaminant Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000009469 supplementation Effects 0.000 description 5
- 208000031886 HIV Infections Diseases 0.000 description 4
- 241000700721 Hepatitis B virus Species 0.000 description 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
- 241000551546 Minerva Species 0.000 description 4
- 206010051606 Necrotising colitis Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 4
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 241000193755 Bacillus cereus Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 241001148470 aerobic bacillus Species 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 235000021049 nutrient content Nutrition 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 2
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
- 206010022840 Intraventricular haemorrhage Diseases 0.000 description 2
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 2
- UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960003920 cocaine Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 229960001252 methamphetamine Drugs 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- 229940005483 opioid analgesics Drugs 0.000 description 2
- 229960002085 oxycodone Drugs 0.000 description 2
- 229960005118 oxymorphone Drugs 0.000 description 2
- 235000016236 parenteral nutrition Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 201000009032 substance abuse Diseases 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241001660259 Cereus <cactus> Species 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010041092 Small for dates baby Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000012865 aseptic processing Methods 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000011213 bioburden testing Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000321 buccal mucosa cell Anatomy 0.000 description 1
- -1 but not limited to Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000012068 polygenic analysis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C13/00—Cream; Cream preparations; Making thereof
- A23C13/12—Cream preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779781P | 2013-03-13 | 2013-03-13 | |
| US61/779,781 | 2013-03-13 | ||
| PCT/US2014/020837 WO2014158911A1 (en) | 2013-03-13 | 2014-03-05 | High fat human milk products |
| CN201480025425.6A CN105246342A (zh) | 2013-03-13 | 2014-03-05 | 高脂人乳产品 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480025425.6A Division CN105246342A (zh) | 2013-03-13 | 2014-03-05 | 高脂人乳产品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114794241A true CN114794241A (zh) | 2022-07-29 |
Family
ID=51528165
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480025425.6A Pending CN105246342A (zh) | 2013-03-13 | 2014-03-05 | 高脂人乳产品 |
| CN202210553069.1A Pending CN114794241A (zh) | 2013-03-13 | 2014-03-05 | 高脂人乳产品 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480025425.6A Pending CN105246342A (zh) | 2013-03-13 | 2014-03-05 | 高脂人乳产品 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US11122813B2 (enExample) |
| EP (3) | EP2967094B1 (enExample) |
| JP (2) | JP6853665B2 (enExample) |
| CN (2) | CN105246342A (enExample) |
| AU (2) | AU2014241754B2 (enExample) |
| BR (1) | BR112015022059B1 (enExample) |
| CA (1) | CA2902990C (enExample) |
| DK (2) | DK3821713T3 (enExample) |
| ES (2) | ES2843254T3 (enExample) |
| FI (1) | FI3821713T3 (enExample) |
| IL (1) | IL240601B (enExample) |
| MX (1) | MX386497B (enExample) |
| PL (2) | PL2967094T3 (enExample) |
| PT (2) | PT3821713T (enExample) |
| WO (1) | WO2014158911A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105246342A (zh) | 2013-03-13 | 2016-01-13 | 普罗莱克塔生物科学公司 | 高脂人乳产品 |
| AU2015374053B2 (en) * | 2014-12-30 | 2020-04-09 | Prolacta Bioscience, Inc. | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
| SG11201805635RA (en) | 2015-12-30 | 2018-07-30 | Prolacta Bioscience Inc | Human milk products useful in pre- and post-operative care |
| WO2022148549A1 (en) | 2020-01-14 | 2022-07-14 | Babylat Gmbh | Apparatus and method for obtaining protein-enriched fractions from breast milk |
| WO2021146561A1 (en) * | 2020-01-17 | 2021-07-22 | Prolacta Bioscience, Inc. | Feeding protocol for optimal growth of preterm infants |
| AU2022211396A1 (en) | 2021-01-22 | 2023-06-29 | Prolacta Bioscience, Inc. | Topical human milk formulations |
| WO2022204463A1 (en) | 2021-03-26 | 2022-09-29 | Prolacta Bioscience, Inc. | Methods of treatment for failure to thrive |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080124430A1 (en) * | 2006-11-29 | 2008-05-29 | Medo Elena M | Human Milk Compositions and Methods of Making and Using Same |
| CN102438466A (zh) * | 2009-05-19 | 2012-05-02 | 荷兰纽迪希亚公司 | 用于改善人体脂肪组织分布的含有高蛋白质和长链多不饱和脂肪酸的人乳强化剂 |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2567898A (en) | 1945-03-19 | 1951-09-11 | Separator Ab | Method of standardizing cream |
| US3946113A (en) | 1972-08-21 | 1976-03-23 | Economics Laboratory, Inc. | Continuous separating and standardizing of milk |
| SE380422B (sv) | 1974-03-07 | 1975-11-10 | Alfa Laval Ab | Foerfaringssaett foer separering av flytande mjoelkprodukter |
| DE3040171C2 (de) | 1980-10-24 | 1986-05-22 | Max-Josef Dr.-Ing. Zürich Schönhuber | Datenregistriersystem zur Erfassung der Daten von bestimmten Gutmengen, insbesondere von Milchlieferungen |
| US4362697A (en) | 1981-04-20 | 1982-12-07 | Miles Laboratories, Inc. | Homogeneous specific binding assay test device having copolymer enhancing substance |
| JPS6133895U (ja) | 1984-07-31 | 1986-03-01 | 東レ株式会社 | 加熱ロ−ラ装置 |
| SE451791B (sv) | 1984-09-11 | 1987-11-02 | Alfa Laval Food & Dairy Eng | Sett och anleggning for framstellning av mjolk med lag bakteriehalt |
| US4772262A (en) | 1985-04-16 | 1988-09-20 | Natural Technologies, Inc. | Portable electric breast pump |
| US4762822A (en) | 1985-08-08 | 1988-08-09 | Ettinger Anna C | Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides |
| US5310893A (en) | 1986-03-31 | 1994-05-10 | Hoffmann-La Roche Inc. | Method for HLA DP typing |
| JPS6467141A (en) | 1987-09-08 | 1989-03-13 | Kougakushiya Kk | Method for removing various germs and somatic cell from cow's milk and apparatus therefor |
| NZ228690A (en) | 1988-04-13 | 1991-10-25 | Snow Brand Milk Products Co Ltd | Continuous production of cheese curds from ultrafiltrated milk |
| US6020015A (en) | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
| US5064674A (en) | 1989-01-13 | 1991-11-12 | Immunopath Profile, Inc. | Hypoallergenic milk products and process of making |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| US5334822A (en) | 1990-05-21 | 1994-08-02 | Universal Computer Technologies Inc. | Method and system for inventoring a distributed plurality of items on a supply |
| DE4018468A1 (de) | 1990-06-08 | 1991-12-12 | Ultrakust Electronic Gmbh | Verfahren und vorrichtung zur entnahme einer repraesentativen milchprobe |
| US5972337A (en) | 1990-11-01 | 1999-10-26 | Cancer Research Fund Of Contra Costa | 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein |
| AU651228B2 (en) | 1991-05-31 | 1994-07-14 | Genentech Inc. | Treatment of HIV-associated immune thrombocytopenic purpura |
| US5169766A (en) | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
| FR2681312A1 (fr) | 1991-09-16 | 1993-03-19 | Francais Prod Ind Cfpi | Solution lubrifiante et desinfectante pour chaine transporteuse de recipients dans l'industrie agro-alimentaire et procede pour sa mise en óoeuvre. |
| US5616483A (en) | 1992-06-11 | 1997-04-01 | Aktiebolaget Astra | Genomic DNA sequences encoding human BSSL/CEL |
| US6056978A (en) | 1992-06-16 | 2000-05-02 | Stolle Milk Biologics, Inc. | Use of hyperimmune milk to prevent suppression of T-lymphocyte production |
| US5256437A (en) | 1992-06-19 | 1993-10-26 | Pall Corporation | Product and process of making sterile milk through dynamic microfiltration |
| AU5896194A (en) | 1992-10-30 | 1994-05-24 | Cancer Research Fund Of Contra Costa | Anti-diarrheic product and method of treating rotavirus-associated infection |
| JP3150504B2 (ja) | 1993-02-26 | 2001-03-26 | 雪印乳業株式会社 | 低乳糖乳製品およびその製造方法 |
| DK169510B1 (da) | 1993-05-13 | 1994-11-14 | Apv Pasilac As | Anlæg og fremgangsmåde til behandling af mælk |
| DE4326665C2 (de) | 1993-08-09 | 1995-07-13 | Biotest Pharma Gmbh | Verfahren zur Sterilfiltration von Milch |
| US5340603A (en) | 1993-08-30 | 1994-08-23 | Abbott Laboratories | Nutritional product for human infants having chronic lung disease |
| US5707678A (en) | 1995-04-12 | 1998-01-13 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| US5670196A (en) | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| US5983198A (en) | 1996-04-23 | 1999-11-09 | Novus International, Inc. | Integrated system monitoring use of materials, controlling and monitoring delivery of materials and providing automated billing of delivered materials |
| US5798266A (en) | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
| US6194009B1 (en) | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
| US6652900B2 (en) | 1997-03-14 | 2003-11-25 | Tetra Laval Holdings & Finance S.A. | Method and plant for producing a sterile milk product |
| SE519853E (sv) | 1997-06-19 | 2005-03-29 | Tetra Laval Holdings & Finance | Metod för framställning av steril skummjölk |
| US6017511A (en) | 1997-05-30 | 2000-01-25 | Resolution Pharmaceuticals Inc. | Glycopeptide-chelator conjugates |
| GB9713597D0 (en) | 1997-06-28 | 1997-09-03 | Sec Dep Of The Home Department | Improvements in and relating to forensic identification |
| US6846298B1 (en) | 1997-07-25 | 2005-01-25 | Bristol-Myers Squibb Company | Blood product delivery system |
| US6004288A (en) | 1998-11-24 | 1999-12-21 | Hochstedler; Judy R. | Breast pump |
| NL1010829C2 (nl) | 1998-12-16 | 2000-06-19 | Prolion Bv | Inrichting en werkwijze voor het melken van dieren en een vervuilingsmeter. |
| ES2187115T3 (es) | 1999-01-20 | 2003-05-16 | Nutricia Nv | Preparado para lactantes. |
| WO2000043550A2 (en) | 1999-01-21 | 2000-07-27 | Wayne State University | Method and apparatus for measuring factors in mammary fluids |
| US20010049096A1 (en) | 1999-03-23 | 2001-12-06 | Stephen J. Brown | Sample identification with analyte determination |
| US6294206B1 (en) | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
| FI110752B (fi) | 1999-05-25 | 2003-03-31 | Novatreat Oy | Menetelmä ternimaidon käsittelemiseksi |
| DK174656B1 (da) | 1999-06-04 | 2003-08-11 | Apv Pasilac As | Fremgangsmåde og anlæg til behandling af mælk |
| US6183803B1 (en) | 1999-06-11 | 2001-02-06 | Biosante Pharmaceuticals, Inc. | Method for processing milk |
| US6780987B1 (en) | 1999-12-10 | 2004-08-24 | Trustees Of The Tufts College | β-cap73 control of normal and abnormal cell migration |
| US20020155445A1 (en) | 1999-12-16 | 2002-10-24 | Jarvik Jonathan W. | Methods and products for peptide based DNA sequence identification and analysis |
| US6670124B1 (en) | 1999-12-20 | 2003-12-30 | Stemcyte, Inc. | High throughput methods of HLA typing |
| WO2001065463A2 (en) | 2000-03-01 | 2001-09-07 | Gambro, Inc. | Extracorporeal blood processing information management system |
| US6737096B2 (en) | 2000-03-29 | 2004-05-18 | Tetra Laval Holdings & Finance S.A. | Method and apparatus for producing a sterile milk product |
| JP2002068998A (ja) | 2000-08-29 | 2002-03-08 | Meiji Milk Prod Co Ltd | 経腸栄養および静脈栄養に伴う脂肪肝発生予防組成物 |
| CN1299771C (zh) | 2000-11-15 | 2007-02-14 | 冯泰拉合作集团有限公司 | 基于初乳的组合物 |
| AU2002311897A1 (en) | 2001-05-09 | 2002-11-18 | Third Wave Technologies, Inc. | Nucleic acid detection in pooled samples |
| US20020182243A1 (en) | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| US20070203802A1 (en) | 2005-09-23 | 2007-08-30 | Prolacta Bioscience, Inc. | Method for collecting, testing and distributing milk |
| US20070098863A1 (en) | 2005-09-23 | 2007-05-03 | Prolacta Bioscience, Inc. | Method for collecting, testing and distributing milk |
| US20100268658A1 (en) | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
| US6866994B2 (en) | 2001-05-30 | 2005-03-15 | Neomatrix, Llc | Noninvasive intraductal fluid diagnostic screen |
| US20030093171A1 (en) | 2001-07-19 | 2003-05-15 | Creative Edge Design Group, Ltd. | Flexible label printing assembly |
| US6875459B2 (en) | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
| FI115752B (fi) | 2002-05-14 | 2005-07-15 | Valio Oy | Menetelmä käytettäväksi vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi |
| US6910594B2 (en) | 2002-11-19 | 2005-06-28 | The First Years Inc. | Method and apparatus for storing milk |
| US7951410B2 (en) | 2003-04-14 | 2011-05-31 | Mead Johnson Nutrition Company | Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid |
| US7867541B2 (en) | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
| PL1638416T3 (pl) | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
| CA2530170A1 (en) | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
| NZ527434A (en) | 2003-08-07 | 2006-03-31 | Fonterra Co Operative Group | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese |
| CA2542612A1 (en) | 2003-10-14 | 2005-04-21 | Kingston Henry Gordon Mills | Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
| WO2005051088A2 (en) | 2003-11-12 | 2005-06-09 | Abbott Laboratories | Iron-containing human milk fortifier with improved antimicrobial properties |
| JP2007526943A (ja) | 2004-03-04 | 2007-09-20 | エイチティーエル ハイ − テック リピッズ リミテッド | 構造化されたトリグリセリド類およびそれを含むエマルション類 |
| US20050214358A1 (en) | 2004-03-23 | 2005-09-29 | Riken | Composition for promoting development of nervous system |
| EP1637043A1 (en) | 2004-09-17 | 2006-03-22 | Medela Holding AG | Human milk fortifiers and methods for their production |
| JP2008512656A (ja) | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
| US20080187619A1 (en) | 2004-09-10 | 2008-08-07 | Medela Holding Ag | Human Milk Fortifiers and Methods for Their Production |
| US20060115558A1 (en) | 2004-11-30 | 2006-06-01 | Jean-Claude Lamothe | Method of production and control of animal derived food products and derivatives thereof |
| CA2537452C (en) | 2005-03-09 | 2013-12-24 | Abbott Laboratories | Concentrated human milk fortifier liquid |
| US20060233915A1 (en) | 2005-04-15 | 2006-10-19 | Bristol-Myers Squibb Company | Liquid nutritional product to supplement human milk |
| US20090203592A1 (en) | 2005-07-01 | 2009-08-13 | N.V. Nutricia | Infant nutrition with hydrolised proteins |
| WO2007035870A2 (en) | 2005-09-20 | 2007-03-29 | Prolacta Bioscience, Inc. | A method for testing milk |
| WO2008027572A1 (en) | 2006-08-30 | 2008-03-06 | Prolacta Bioscience | Methods of obtaining sterile milk and compositions thereof |
| US8377445B2 (en) | 2006-12-08 | 2013-02-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
| WO2008119163A1 (en) | 2007-03-29 | 2008-10-09 | The Hospital For Sick Children | Multi-nutrient milk fortifier |
| US20080254165A1 (en) | 2007-04-12 | 2008-10-16 | Rashid Patel | Novel manufacturing process for milk acid |
| US20090181848A1 (en) | 2007-07-06 | 2009-07-16 | Ep Minerals, Llc | Crystalline silica-free diatomaceous earth blended filter aids and methods of manufacturing the same |
| ES2426591T5 (es) * | 2007-10-09 | 2017-08-16 | Enzymotec Ltd. | Composiciones de lípidos para el tratamiento de trastornos gastrointestinales |
| JP2011504365A (ja) | 2007-11-26 | 2011-02-10 | ネステク ソシエテ アノニム | 乳児のための年齢に合わせた栄養システム |
| US20100069716A1 (en) | 2008-09-12 | 2010-03-18 | Yem Chin | Flexible guide conduit |
| JP2010126495A (ja) | 2008-11-28 | 2010-06-10 | Morinaga Milk Ind Co Ltd | 母乳添加用粉末 |
| CN102300575A (zh) * | 2008-12-02 | 2011-12-28 | 普罗莱克塔生物科学公司 | 人乳渗透物组合物及其制备和使用方法 |
| WO2011144221A1 (en) | 2010-05-18 | 2011-11-24 | N.V. Nutricia | Preterm milk formula |
| WO2012030764A2 (en) | 2010-08-30 | 2012-03-08 | Neolac, Inc. | Human milk preparation |
| MX355780B (es) | 2010-12-31 | 2018-04-30 | Abbott Lab | Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. |
| US8563611B2 (en) | 2011-03-17 | 2013-10-22 | Women's & Children's Health Research Institute | Methods and compositions for promoting the respiratory development of an infant |
| DK2739157T3 (en) | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
| CN102511557B (zh) | 2011-12-29 | 2015-06-17 | 内蒙古伊利实业集团股份有限公司 | 一种适用于初生到6个月的液态婴儿奶及其生产方法 |
| US20140271980A1 (en) | 2013-03-13 | 2014-09-18 | Prolacta Bioscience | Adulteration testing of human milk |
| CN105246342A (zh) | 2013-03-13 | 2016-01-13 | 普罗莱克塔生物科学公司 | 高脂人乳产品 |
| AU2015374053B2 (en) | 2014-12-30 | 2020-04-09 | Prolacta Bioscience, Inc. | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
| WO2016168698A1 (en) | 2015-04-15 | 2016-10-20 | Prolacta Bioscience, Inc. | Human milk compositions and methods of making and using same |
| SG11201805635RA (en) | 2015-12-30 | 2018-07-30 | Prolacta Bioscience Inc | Human milk products useful in pre- and post-operative care |
| EP3643179A4 (en) | 2018-09-13 | 2020-04-29 | Original Biological Technology Co., Ltd. | NUTRITIONAL POWDER MILK FOR INFANTS UNDERGOING CONGENITAL HEART DISEASE, NON-CARDIAC SURGERY OR IN INTENSIVE CARE, AND METHOD OF USE THEREOF |
-
2014
- 2014-03-05 CN CN201480025425.6A patent/CN105246342A/zh active Pending
- 2014-03-05 MX MX2015012205A patent/MX386497B/es unknown
- 2014-03-05 PT PT202160917T patent/PT3821713T/pt unknown
- 2014-03-05 EP EP14774486.6A patent/EP2967094B1/en active Active
- 2014-03-05 WO PCT/US2014/020837 patent/WO2014158911A1/en not_active Ceased
- 2014-03-05 EP EP24219978.4A patent/EP4520179A3/en active Pending
- 2014-03-05 PL PL14774486T patent/PL2967094T3/pl unknown
- 2014-03-05 PT PT147744866T patent/PT2967094T/pt unknown
- 2014-03-05 PL PL20216091.7T patent/PL3821713T3/pl unknown
- 2014-03-05 JP JP2016500678A patent/JP6853665B2/ja active Active
- 2014-03-05 AU AU2014241754A patent/AU2014241754B2/en active Active
- 2014-03-05 DK DK20216091.7T patent/DK3821713T3/da active
- 2014-03-05 FI FIEP20216091.7T patent/FI3821713T3/fi active
- 2014-03-05 CN CN202210553069.1A patent/CN114794241A/zh active Pending
- 2014-03-05 US US14/198,432 patent/US11122813B2/en active Active
- 2014-03-05 ES ES14774486T patent/ES2843254T3/es active Active
- 2014-03-05 ES ES20216091T patent/ES3015561T3/es active Active
- 2014-03-05 CA CA2902990A patent/CA2902990C/en active Active
- 2014-03-05 BR BR112015022059-2A patent/BR112015022059B1/pt active IP Right Grant
- 2014-03-05 DK DK14774486.6T patent/DK2967094T3/da active
- 2014-03-05 EP EP20216091.7A patent/EP3821713B1/en active Active
-
2015
- 2015-08-17 IL IL240601A patent/IL240601B/en active IP Right Grant
-
2018
- 2018-02-28 AU AU2018201444A patent/AU2018201444B2/en active Active
-
2019
- 2019-05-15 US US16/412,699 patent/US11419342B2/en active Active
- 2019-09-25 JP JP2019174723A patent/JP2020043854A/ja active Pending
-
2022
- 2022-07-13 US US17/863,999 patent/US12063943B2/en active Active
-
2024
- 2024-06-28 US US18/759,044 patent/US20250017228A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080124430A1 (en) * | 2006-11-29 | 2008-05-29 | Medo Elena M | Human Milk Compositions and Methods of Making and Using Same |
| CN101626697A (zh) * | 2006-11-29 | 2010-01-13 | 普罗莱克塔生物科学公司 | 人乳组合物及其制备和使用方法 |
| CN102438466A (zh) * | 2009-05-19 | 2012-05-02 | 荷兰纽迪希亚公司 | 用于改善人体脂肪组织分布的含有高蛋白质和长链多不饱和脂肪酸的人乳强化剂 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12063943B2 (en) | High fat human milk products | |
| AU2015374053B2 (en) | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products | |
| AU2016249380B2 (en) | Human milk compositions and methods of making and using same | |
| HK40051822A (en) | High fat human milk products | |
| HK40051822B (en) | High fat human milk products | |
| HK1220328B (en) | High fat human milk products | |
| CA3213191A1 (en) | Methods of treatment for failure to thrive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220729 |
|
| RJ01 | Rejection of invention patent application after publication |